venBio Select Advisor LLC Buys MyoKardia Inc, Amarin Corp PLC, Array BioPharma Inc, Sells Loxo Oncology Inc, TG Therapeutics Inc, PTC Therapeutics Inc

• New Purchases: MYOK, ARRY, MDCO, ACAD, CBAY,
• Added Positions: AMRN, GBT, BDSI, MDGL, IOVA,
• Reduced Positions: MRTX, BMRN, ASND, SRPT, HZNP, FOLD, ASMB, ZGNX, ARGX, TCDA, TLGT,
• Sold Out: LOXO, TGTX, PTCT, YMAB, PTI, ACER,

For the details of venBio Select Advisor LLC's stock buys and sells, go to https://www.gurufocus.com/guru/venbio+select+advisor+llc/current-portfolio/portfolio

1. Immunomedics Inc (IMMU) - 17,714,461 shares, 14.94% of the total portfolio.
2. Mirati Therapeutics Inc (MRTX) - 3,862,500 shares, 12.43% of the total portfolio. Shares reduced by 19.5%
3. Ascendis Pharma A/S (ASND) - 1,795,000 shares, 9.27% of the total portfolio. Shares reduced by 9.34%
4. Amarin Corp PLC (AMRN) - 8,000,000 shares, 7.29% of the total portfolio. Shares added by 43.50%
5. Sarepta Therapeutics Inc (SRPT) - 1,195,000 shares, 6.25% of the total portfolio. Shares reduced by 6.27%

venBio Select Advisor LLC initiated holding in MyoKardia Inc. The purchase prices were between $39.23 and $55.82, with an estimated average price of $46.05. The stock is now traded at around $50.14. The impact to a portfolio due to this purchase was 2.28%. The holding were 1,000,000 shares as of .

venBio Select Advisor LLC initiated holding in Array BioPharma Inc. The purchase prices were between $14.25 and $24.45, with an estimated average price of $20.7. The stock is now traded at around $46.33. The impact to a portfolio due to this purchase was 2.14%. The holding were 2,000,000 shares as of .

venBio Select Advisor LLC initiated holding in The Medicines Co. The purchase prices were between $17.86 and $28.02, with an estimated average price of $23.46. The stock is now traded at around $36.47. The impact to a portfolio due to this purchase was 1.92%. The holding were 1,562,000 shares as of .

venBio Select Advisor LLC initiated holding in ACADIA Pharmaceuticals Inc. The purchase prices were between $16.17 and $27.38, with an estimated average price of $23.2. The stock is now traded at around $26.73. The impact to a portfolio due to this purchase was 1.56%. The holding were 1,325,000 shares as of .

venBio Select Advisor LLC initiated holding in CymaBay Therapeutics Inc. The purchase prices were between $7.87 and $13.42, with an estimated average price of $10.56. The stock is now traded at around $7.16. The impact to a portfolio due to this purchase was 0.42%. The holding were 725,000 shares as of .

venBio Select Advisor LLC added to a holding in Amarin Corp PLC by 43.50%. The purchase prices were between $12.61 and $22.33, with an estimated average price of $17.95. The stock is now traded at around $19.39. The impact to a portfolio due to this purchase was 2.21%. The holding were 8,000,000 shares as of .

venBio Select Advisor LLC added to a holding in Global Blood Therapeutics Inc by 171.43%. The purchase prices were between $39.99 and $53.48, with an estimated average price of $49.06. The stock is now traded at around $52.60. The impact to a portfolio due to this purchase was 1.4%. The holding were 950,000 shares as of .

venBio Select Advisor LLC added to a holding in BioDelivery Sciences International Inc by 57.14%. The purchase prices were between $3.65 and $5.3, with an estimated average price of $4.55. The stock is now traded at around $4.65. The impact to a portfolio due to this purchase was 0.63%. The holding were 7,424,867 shares as of .

venBio Select Advisor LLC added to a holding in Madrigal Pharmaceuticals Inc by 37.78%. The purchase prices were between $103.48 and $143.84, with an estimated average price of $124.23. The stock is now traded at around $104.81. The impact to a portfolio due to this purchase was 0.47%. The holding were 310,000 shares as of .

venBio Select Advisor LLC sold out a holding in Loxo Oncology Inc. The sale prices were between $131.02 and $234.75, with an estimated average price of $222.49.

venBio Select Advisor LLC sold out a holding in TG Therapeutics Inc. The sale prices were between $4.02 and $8.04, with an estimated average price of $5.36.

venBio Select Advisor LLC sold out a holding in PTC Therapeutics Inc. The sale prices were between $28.09 and $39.49, with an estimated average price of $33.54.

venBio Select Advisor LLC sold out a holding in Y-mAbs Therapeutics Inc. The sale prices were between $18.21 and $26.21, with an estimated average price of $21.95.

venBio Select Advisor LLC sold out a holding in Proteostasis Therapeutics Inc. The sale prices were between $1.24 and $4.46, with an estimated average price of $3.49.

venBio Select Advisor LLC sold out a holding in Acer Therapeutics Inc. The sale prices were between $20.12 and $25.15, with an estimated average price of $23.57.